+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
HER2 Positive Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Positive Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Colorectal Neoplasm - Pipeline Insight, 2025 - Product Thumbnail Image

Colorectal Neoplasm - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Myelocytic Leukemia (CML) - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Myelocytic Leukemia (CML) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Carcinoid Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Carcinoid Tumor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Brain Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Cancer Pain Management - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025 - Product Thumbnail Image

chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Fatty Pancreas - Pipeline Insight, 2025 - Product Thumbnail Image

Fatty Pancreas - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TRK Fusion Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

TRK Fusion Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
MDS - Pipeline Insight, 2025 - Product Thumbnail Image

MDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HR-Positive-HER-negative - Pipeline Insight, 2025 - Product Thumbnail Image

HR-Positive-HER-negative - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more